Australia Veterinary Healthcare Market 2026 | Projected to Reach USD 1,733.2 Million by 2034

Market Overview

The Australia veterinary healthcare market size reached USD 990.6 Million in 2025 and is expected to reach USD 1,733.2 Million by 2034, exhibiting a growth rate (CAGR) of 6.22% during 2026-2034. The market encompasses diverse product categories, animal types, and end-user segments tailored to various animal healthcare needs, covering therapeutics and diagnostics across companion animals, livestock, and equine categories addressed through veterinary hospitals, clinics, and laboratory testing services. The market is witnessing significant growth, driven by rising pet ownership, growing awareness about animal health, and increased spending on preventive and therapeutic care. Advancements in veterinary diagnostics, pharmaceuticals, and surgical procedures are enhancing treatment outcomes for both companion and livestock animals. Government support for animal disease control and livestock management are also contributing positively to the sector - positioning it for sustained expansion throughout the forecast period.

Request for a sample report PDF: https://www.imarcgroup.com/australia-veterinary-healthcare-market/requestsample

Australia Veterinary Healthcare Market Summary

• Expansion is driven by exceptionally high pet ownership, with 58% of Victorians owning pets across 1.4 million households - with dogs at 41% and cats at 24% ownership rates - reflecting a nationwide trend of pets being treated as family members

• Strong humanization of pets is compelling owners to invest in regular check-ups, immunization, and advanced treatments that mirror the standards of human healthcare spending

• Growing demand for digital veterinary services is transforming care accessibility, with Dial A Vet announcing in September 2024 its plans to offer 24/7 licensed veterinarian access to 7 million Australian households at affordable AUD 25 consultation rates

• Market includes therapeutics covering vaccines, parasiticides, anti-infectives, and medical feed additives, and diagnostics covering immunodiagnostic tests, molecular diagnostics, diagnostic imaging, and clinical chemistry

• Demand is rising for AI-powered diagnostic tools including SK Telecom's X Caliber service launched in May 2024, enabling rapid AI-assisted X-ray image analysis for pets across more than 100 Australian clinics

• Growth in livestock healthcare investment is supported by government animal disease control programs, export market quality requirements, and advances in veterinary feed additives and reproductive health management

• Advancements in veterinary diagnostics, pharmaceuticals, and minimally invasive surgical procedures are continuously improving treatment outcomes for companion animals and commercial livestock species

• Telehealth and mobile veterinary clinic services are expanding access in remote and rural communities where geographic distance historically limited timely veterinary care availability

• Australia Capital Territory and New South Wales anchor market leadership through Sydney's concentration of specialist veterinary hospitals, diagnostic laboratories, and high-income urban pet-owning populations

How AI is Reshaping the Australia Veterinary Healthcare Market

Artificial intelligence is playing an increasingly pivotal role in reshaping the Australia veterinary healthcare market, enabling veterinary hospitals, diagnostic laboratories, pharmaceutical companies, and telehealth platforms to streamline clinical operations, improve diagnostic accuracy, and deliver more responsive, data-driven animal healthcare solutions across diverse companion animal and livestock segments.

• AI-Powered Veterinary Diagnostic Imaging and Pathology Analysis: Veterinary diagnostic service providers are deploying AI-based image analysis platforms - as demonstrated by SK Telecom's X Caliber service launched in Australia in May 2024 for rapid AI-assisted X-ray interpretation across more than 100 clinics - enabling faster and more accurate identification of fractures, tumors, and internal conditions that improve diagnostic efficiency and clinical decision-making for veterinary practitioners.

• Predictive Animal Health Monitoring and Disease Surveillance: Livestock producers and veterinary healthcare providers are integrating AI-powered animal health monitoring platforms that analyze biometric data, behavioral patterns, and environmental conditions - enabling early identification of disease outbreaks, nutritional deficiencies, and reproductive health issues that reduce treatment costs and protect herd productivity across Australia's extensive cattle, sheep, and poultry farming operations.

• AI-Enabled Telehealth Triage and Remote Consultation Support: Digital veterinary platforms including Dial A Vet are deploying AI-assisted triage systems that assess symptom descriptions, guide pet owners through preliminary health assessments, and prioritize consultation urgency - enabling more efficient allocation of licensed veterinarian time while expanding affordable care access for 7 million Australian households across both urban and remote communities.

• Intelligent Pharmaceutical Inventory and Supply Chain Management: Veterinary pharmaceutical distributors and clinic operators are adopting AI-powered inventory management systems that analyze prescription patterns, seasonal disease trends, and regional demand variations - enabling optimized drug stock management, reduced medication waste, and more reliable availability of critical vaccines, parasiticides, and therapeutic medications across veterinary service networks.

• AI-Driven Personalized Treatment Planning and Clinical Decision Support: Veterinary practitioners are integrating AI-powered clinical decision support tools that analyze patient history, diagnostic results, species-specific pharmacology, and treatment outcome data - enabling more evidence-based therapeutic recommendations, optimized drug dosing protocols, and improved management of chronic conditions in companion animals and high-value livestock.

• Fraud Detection and Veterinary Product Authenticity Verification: AI-driven supply chain monitoring systems are enabling veterinary pharmaceutical distributors and regulatory authorities to identify counterfeit medications, unauthorized product substitutions, and non-registered therapeutic claims - protecting animal patient safety and practitioner liability in a regulated healthcare environment where product authenticity is critical to treatment efficacy and safety.

• Data Privacy and Secure Digital Veterinary Infrastructure Through AI Governance: In alignment with Australia's Privacy Act and veterinary sector digital compliance frameworks, AI-powered governance tools are enabling telehealth platforms and digital health record systems to maintain regulatory compliance - ensuring secure management of patient health data, diagnostic records, and prescription histories while building trust in digital veterinary service delivery across the country.

Key Trends Shaping the Australia Veterinary Healthcare Market

• Rising pet ownership and pet humanization are the foundational structural drivers, with Australian households increasingly treating companion animals as family members and making non-discretionary healthcare investments in routine wellness care, preventive vaccinations, specialist consultations, and advanced diagnostic and surgical interventions that mirror the quality standards applied to human family healthcare spending.

• Digital veterinary services and telehealth are rapidly transforming care accessibility and convenience, with Dial A Vet's announced expansion to 24/7 nationwide licensed veterinarian access at AUD 25 per consultation demonstrating the strong consumer appetite for affordable, on-demand veterinary guidance - particularly in remote and rural areas where geographic distance has historically created significant barriers to timely animal healthcare access.

• AI-powered diagnostic innovation is elevating the standard and speed of veterinary clinical care, with SK Telecom's X Caliber AI diagnostic imaging service - available across more than 100 Australian clinics from May 2024 - enabling faster radiological interpretation that reduces diagnostic turnaround times and supports more timely treatment initiation for companion animal patients across the country.

• Livestock healthcare investment is sustained by Australia's critical role as a global agricultural exporter, with producers investing in veterinary preventive care, nutritional optimization, and disease surveillance programs to protect herd productivity, meet international biosecurity standards, and comply with export market quality requirements that underpin Australia's multi-billion-dollar livestock export industry.

• Advanced therapeutic and nutritional product innovation is expanding treatment capabilities across both companion animal and production animal segments, with NOVUS's November 2024 launch of new dairy nutrition solutions in Australia and New Zealand - including MFP Feed Supplement for milk component optimization, MINTREX trace minerals for reproductive health, and ZORIEN SeY 3000 Prilled Yeast for selenium absorption - exemplifying the growing sophistication of specialized veterinary nutrition products.

• Mobile veterinary clinics and on-site service delivery models are gaining adoption among urban pet owners and rural farming communities, with mobile units providing vaccinations, health check-ups, and minor treatments that reduce pet transportation stress, improve access in underserved areas, and enable follow-up chronic condition management without disrupting the animal's home environment.

• Australia Capital Territory and New South Wales lead regional veterinary healthcare market performance through Sydney's extraordinary concentration of specialist veterinary hospitals, advanced diagnostic imaging centers, and veterinary teaching facilities - while Victoria and Tasmania, Queensland, and Western Australia represent significant companion and livestock veterinary markets supported by dense pet ownership populations and extensive agricultural production industries.

Browse the full report with TOC and list of figures: https://www.imarcgroup.com/australia-veterinary-healthcare-market

Market Growth Drivers

Pet Ownership Growth, Humanization Trends, and Preventive Healthcare Investment

The Australia veterinary healthcare market growth is anchored in the extraordinary depth of Australian pet ownership - with millions of companion animals across the country and a powerful cultural shift treating pets as family members - compelling pet owners to invest consistently in preventive wellness care, vaccination programs, dental health, and specialist treatments that drive sustained and growing demand for veterinary pharmaceutical, diagnostic, and clinical service products. The humanization of pets is simultaneously raising spending standards, with millennial and Gen Z pet owners particularly willing to invest in advanced diagnostics, specialist referrals, oncology treatments, and rehabilitation services that reflect their emotional investment in companion animal wellbeing. The growing awareness of preventive healthcare value among pet owners - reinforced by veterinary professional education campaigns, digital health content, and telehealth platform consultations - is shifting spending from reactive treatment toward proactive wellness management, expanding the addressable market for vaccines, parasiticides, health monitoring services, and nutritional products throughout the 2026-2034 forecast period.

Digital Innovation, Livestock Sector Demand, and Government Support

The rapid advancement of digital veterinary services - encompassing AI-powered diagnostic imaging, telehealth platforms, remote monitoring systems, and mobile clinic models - is simultaneously improving clinical efficiency, expanding care accessibility across geographic barriers, and creating new revenue channels for veterinary service providers that broaden the market's growth foundation beyond traditional clinic-based consultation models. Australia's world-leading livestock production industry generates substantial and sustained demand for veterinary pharmaceuticals, feed additives, reproductive health management products, and biosecurity programs - with producers investing proactively in animal health to protect herd productivity, minimize disease-related losses, and comply with the stringent biosecurity standards required for Australia's export market access. Government support through animal disease surveillance programs, livestock health subsidies, and regulatory frameworks that ensure veterinary product quality and safety collectively reinforce the institutional confidence and investment stability that underpin continued market expansion - positioning the Australia veterinary healthcare market as one of the Asia-Pacific region's most robust and consistently growing animal health sectors.

Market Segmentation

IMARC Group provides an analysis of the key trends in each segment of the Australia veterinary healthcare market, along with forecasts at the country and regional levels from 2026-2034. The market has been categorized based on product, animal type, and end user.

By Product:

Therapeutics

• Vaccines
• Parasiticides
• Anti-Infectives
• Medical Feed Additives
• Others

Diagnostics

• Immunodiagnostic Tests
• Molecular Diagnostics
• Diagnostic Imaging
• Clinical Chemistry
• Others

By Animal Type:

• Dogs and Cats
• Horses
• Ruminants
• Swine
• Poultry
• Others

By End User:

• Veterinary Hospitals
• Veterinary Clinics
• Veterinary Laboratory Testing Services
• Others

By Region:

• Australia Capital Territory & New South Wales
• Victoria & Tasmania
• Queensland
• Northern Territory & Southern Australia
• Western Australia

Key Players

The Australia veterinary healthcare market features competition among global veterinary pharmaceutical multinationals, regional animal health companies, specialist veterinary diagnostic service providers, and emerging digital veterinary telehealth platforms. The market research report provides a comprehensive analysis of the competitive landscape including key player positioning, market structure, top winning strategies, competitive dashboards, and detailed company profiles.

Key Aspects Required for Australia Veterinary Healthcare Market

• Demand structure includes companion animal owners, livestock producers, equine operators, poultry farmers, and government animal health programs requiring therapeutic, diagnostic, and preventive veterinary healthcare solutions

• Balanced growth between companion animal healthcare driven by pet humanization and premium spending and production animal healthcare driven by agricultural export requirements and herd productivity management

• Product segmentation includes core vaccines and parasiticides for preventive care, anti-infective therapeutics for disease treatment, specialized feed additives for livestock nutrition, and advanced diagnostic imaging and laboratory testing services

• Increasing preference for preventive and wellness-oriented veterinary care over reactive treatment - driving demand for vaccination programs, regular health screening, dental care, and nutritional supplementation across companion animal segments

• Pet owners and livestock producers prioritize diagnostic accuracy, treatment efficacy, veterinarian expertise, product safety certification, and value for investment in veterinary healthcare provider and product selection

• Growing demand for AI-powered diagnostic tools, telehealth consultation platforms, remote animal monitoring systems, and digital health record management that improve care efficiency and accessibility

• Competitive landscape includes Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, and NOVUS alongside domestic veterinary hospital chains, specialist referral centers, and emerging digital health platforms

• Distribution channels include veterinary hospitals, specialist clinics, farm supply distributors, online veterinary pharmacy platforms, and direct livestock producer supply arrangements

• Expansion of telehealth and mobile veterinary services broadening care access across remote and rural areas previously underserved by traditional clinic-based veterinary infrastructure

• Rising investments in AI-assisted diagnostic imaging, molecular diagnostic testing, and point-of-care testing technologies that improve diagnostic speed, accuracy, and accessibility at clinic level

• Increasing role of Australian Pesticides and Veterinary Medicines Authority (APVMA) regulations in governing veterinary product registration, safety assessment, and market authorization across therapeutic and diagnostic categories

• Growing penetration of specialist veterinary referral services in regional centers as telemedicine platforms enable remote specialist consultation and case co-management between general practitioners and specialist veterinarians

• Integration of veterinary healthcare with pet insurance products, loyalty wellness programs, and digital health monitoring devices that encourage proactive pet healthcare spending and improve treatment adherence

• Rising demand for exotic and avian veterinary specialist services as Australian pet ownership diversifies beyond dogs and cats to include birds, reptiles, and small mammals requiring specialized clinical expertise

• Expansion of equine veterinary services driven by Australia's significant horse racing, breeding, and recreational riding industries generating sustained demand for specialized equine diagnostic and therapeutic products

Recent News and Developments

March 2026: The Philippines veterinary healthcare market (animal health segment) reached approximately USD 181.0 million in 2025, driven by increasing demand for livestock products and rising adoption of veterinary technologies such as vaccines, diagnostics, and therapeutics.

February 2026: The broader animal health and veterinary market in the Philippines is valued at around USD 650-690 million, supported by increasing pet ownership, expansion of livestock farming, and growing awareness of animal welfare and disease prevention.

January 2026: Veterinary services demand is rising significantly, with increasing need for routine check-ups, vaccinations, surgeries, and specialized treatments, fueled by a growing middle class and higher spending on companion animal care.

December 2025: The Philippines animal health market generated approximately USD 648.4 million in 2024, with pharmaceuticals dominating the segment while diagnostics emerged as the fastest-growing category.

November 2025: Veterinary pharmaceuticals are expanding rapidly, with strong demand for vaccines, antibiotics, and anti-inflammatory drugs, supported by rising livestock production and increasing pet healthcare needs.

October 2025: The livestock health segment alone accounted for about USD 417.4 million in 2024, highlighting the critical role of veterinary healthcare in supporting food production and agricultural efficiency.

September 2025: The Philippines continues to show strong pet ownership trends, with around 83% of households owning pets, significantly boosting demand for veterinary healthcare services and preventive treatments.

2025: The veterinary healthcare sector is evolving with technological advancements and regulatory support, including stricter animal welfare laws and increased adoption of diagnostic tools, vaccines, and biosecurity measures to manage zoonotic diseases and improve animal health outcomes.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Speak to an analyst for a customized sample report: https://www.imarcgroup.com/request?type=report&id=34460&flag=C

Contact Us

IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel. No.: (D) +91 120 433 0800
United States: +1-201-971-6302

About Us

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.